CND Life Sciences introduced clinicians to the Syn-One Test™ at the exhibit hall of Vanderbilt University Medical Center’s 44th Annual Contemporary Clinical Neurology Symposium in Hilton Head, SC in July.
New Research Supports Use of Skin Biopsies to Help Diagnose REM Sleep Behavior Disorder, a Prodrome of Parkinson’s Disease
Al-Qassabi and colleagues recently published a study in Movement Disorders that examined whether 3-mm skin punch biopsies could be used to detect synuclein pathology in patients with REM sleep behavior disorder (RBD).
CND Life Sciences continues to increase awareness and adoption of the skin-based Syn-One Test™ for Parkinson’s disease, dementia with Lewy bodies, and other synucleinopathies, now with the new “Power of Proof” campaign, which will appear across several top neurology journals and websites.
At the 2021 American Academy of Neurology meeting last month, Dr Alexandru Barboi and colleagues presented their observations on the use of the Syn-One Test™ in the evaluation of patients with autonomic symptoms.
A team of skilled laboratory professionals are the engine that keeps CND Life Sciences running every day. From the moment a Syn-One Test™ sample arrives, it must be handled and processed according to strict specifications.
In the next installment of our Patient Matters video series, Daryn Kagan talks with Alvin, a patient who was living with unexplained fatigue in his legs.
In a new effort to increase awareness and adoption of the skin-based Syn-One Test™ for Parkinson’s disease, dementia with Lewy bodies, and other synucleinopathies, CND has launched a targeted print and digital campaign across several top neurology journals and websites.
Do you know how many people in the US are diagnosed with Parkinson’s disease each year? Or what percent of cases are thought to have a genetic cause?
Karina Solis always wanted to be a teacher. Her love for education took her from lecturing her stuffed animals as a child to graduating with degrees in Public Health Education and Biology from California State University-Long Beach.
Rare Disease Day is February 28, 2021. EURORDIS, the organizer of Rare Disease Day, works to achieve more equitable access to diagnosis, treatment, care, and social opportunity for those with rare diseases.